1. Aisner, J., Esterhay, R. J., Jr., Wiernik, P. H. Treatment of oat cell carcinoma of the lung with cyclophosphamide, adriamycin, epipodophyllotoxin VP 16-213 and methanol extracted residue (MER) of BCG. Proc. Amer. Ass. Cancer Res., Amer. Soc. clin. Oncol. 17, 261 (1976)
2. Baehner, R. L., Bernstein, I. O., Higgins, G., McCreadie, S., Chard, R. L., Hammond, D.: Improved induction remission response in children with acute non-lymphocytic leukemia treated with daunomycin, 5-azacytidine, cytosine arabinoside, prednisone, and vincristine (D-ZAPO). Proc. Amer. Ass. Cancer Res., Amer. Soc. clin. Oncol. (in press, 1977)
3. Baker, L. H., Opipari, M. I., Izbicki, R. M.: Phase II study of mitomycin C, vincristine, and bleomycin in advanced squamous cell carcinoma of the uterine cervix. Cancer 38, 2222 (1976)
4. Benjamin, R. S., Hall, S. W., Burgess, M. A., Wheeler, W. L., Murphy, W. K., Blumenschein, G. R., Gottlieb, J. A.: A pharmacokinetically based phase I–II study of single dose actinomycin D (NSC-3053). Cancer treat. Rep. 60, 289 (1976)
5. Beretta, G., Bonnadonna, G., Cascinelli, N., Morabito, A., Veronesi, U.: Comparative evaluation of three combination regimens for advanced malignant melanoma; results of an international cooperative study. Cancer treat. Rep. 60, 33 (1976)